MENU
+Compare
INSM
Stock ticker: NASDAQ
AS OF
Jun 25 closing price
Price
$104.85
Change
-$1.05 (-0.99%)
Capitalization
19.92B

INSM Insmed Forecast, Technical & Fundamental Analysis

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases... Show more

Industry: #Biotechnology
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INSM with price predictions
Jun 25, 2025

Momentum Indicator for INSM turns positive, indicating new upward trend

INSM saw its Momentum Indicator move above the 0 level on May 22, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned positive. In of the 103 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for INSM just turned positive on May 19, 2025. Looking at past instances where INSM's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

INSM moved above its 50-day moving average on June 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for INSM crossed bullishly above the 50-day moving average on June 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for INSM moved above the 200-day moving average on June 20, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INSM advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 166 cases where INSM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INSM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INSM broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: INSM's P/B Ratio (200.000) is slightly higher than the industry average of (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). INSM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (47.393) is also within normal values, averaging (255.605).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INSM is expected to report earnings to fall 9.15% to -128 cents per share on July 31

Insmed INSM Stock Earnings Reports
Q2'25
Est.
$-1.29
Q1'25
Missed
by $0.07
Q4'24
Missed
by $0.14
Q3'24
Missed
by $0.07
Q2'24
Missed
by $0.70
The last earnings report on May 08 showed earnings per share of -141 cents, missing the estimate of -135 cents. With 3.53M shares outstanding, the current market capitalization sits at 19.92B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 US Highway 202/206
Phone
+1 908 977-9900
Employees
912
Web
https://www.insmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALT2.510.09
+3.72%
Galectin Therapeutics
CLS149.045.20
+3.62%
Celestica
MRCY50.130.17
+0.34%
Mercury Systems
BNZI0.59-0.03
-4.32%
Banzai International Inc
DCOM25.81-1.34
-4.94%
Dime Community Bancshares

INSM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-0.54%
THAR - INSM
74%
Closely correlated
+8.02%
AGIO - INSM
46%
Loosely correlated
-2.12%
ROIV - INSM
45%
Loosely correlated
-1.21%
KRYS - INSM
42%
Loosely correlated
-0.81%
IONS - INSM
42%
Loosely correlated
+0.91%
More

Groups containing INSM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-0.54%
INSM
(2 stocks)
100%
Closely correlated
+3.74%